AI
CLLS

Atria Investments’s Cellectis CLLS Stock Holding History

Atria Investments’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,998
Closed -$212K – 574
2020
Q1 		$212K Buy
22,998
+5,141
+29% +$76.7K 0.02% 517
2019
Q4 		$306K Buy
+17,857
New +$238K 0.01% 968
2019
Q3 		– Sell
-14,088
Closed -$181K – 881
2019
Q2 		$181K Sell
14,088
-753
-5% -$13.4K 0.01% 919
2019
Q1 		$272K Buy
14,841
+3,546
+31% +$62.8K 0.01% 741
2018
Q4 		$188K Buy
+11,295
New +$262K 0.01% 823

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Atria Investments's CLLS Position: Q2 2020 in Review

Atria Investments sold out of Cellectis (CLLS) in Q2 2020, closing a stake of 22,998 shares — an estimated $212K sold.

Atria Investments first reported a position in CLLS in Q4 2018 and held it in 5 quarters. The position peaked at $306K in Q4 2019. 79 funds tracked by Wall St. Rank hold CLLS as of Q2 2020.

  • Atria Investments reported no remaining Cellectis position as of Q2 2020 after selling out during the quarter.
  • Atria Investments sold 22,998 Cellectis shares in Q2 2020, an estimated $212K.
  • Atria Investments first reported a position in Cellectis in Q4 2018 and held it in 5 quarters.
  • Atria Investments's Cellectis position peaked at $306K in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Cellectis as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.